Headliner: Jim Daly of Amgen
Asked for his take on things now that Amgen is launching its first-ever cancer therapeutic, Jim Daly responds cheerfully.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.